A September 2026 Nature study found semaglutide extended lifespan in older female mice by 12%. A separate human trial found it slowed biological-aging clocks by about 9%. Here is what the evidence actually shows — and does not.
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy A study presented at the 2026 ASCO Annual Meeting is getting attention for a genuinely striking finding: women taking GLP-1 drugs like Ozempic and Wegovy were roughly 30% less likely to develop breast cancer. It’s a […]
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy Everyone knows Ozempic and Wegovy for one reason: weight loss. But in 2026, a wave of new research is revealing something that is catching even doctors off guard. These GLP-1 receptor agonist drugs are doing far […]
Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy Two of the most prescribed weight loss drugs in the world – Ozempic (semaglutide) and Mounjaro (tirzepatide) – are now being scrutinised for a side effect that doctors rarely mention in the consultation room: significant muscle […]